Throughout the week, CNBC is doing a special series on whistleblowers, and much of it concerns the False Claims Act. This morning, Recognizing that there is a huge “cottage industry” out there, CNBC ‘s Eamon Javers reported that pharmaceutical companies have changed their practices as a result of pharmaceutical fraud whistleblower lawsuits. An overview and the schedule is at CNBC.

For more information about qui tam law and pharmaceutical fraud, contact Nolan and Auerbach, P.A.